3iy1 › Citations

Structural comparison of different antibodies interacting with parvovirus capsids.

Hafenstein S, Bowman VD, Sun T, Nelson CD, Palermo LM, Chipman PR, Battisti AJ, Parrish CR, Rossmann MG
J Virol 83 5556-66 (2009)
Related entries: 3gk8, 3iy0, 3iy2, 3iy3, 3iy4, 3iy5, 3iy6, 3iy7

Cited: 56 times
EuropePMC logo PMID: 19321620

Abstract

The structures of canine parvovirus (CPV) and feline parvovirus (FPV) complexed with antibody fragments from eight different neutralizing monoclonal antibodies were determined by cryo-electron microscopy (cryoEM) reconstruction to resolutions varying from 8.5 to 18 A. The crystal structure of one of the Fab molecules and the sequence of the variable domain for each of the Fab molecules have been determined. The structures of Fab fragments not determined crystallographically were predicted by homology modeling according to the amino acid sequence. Fitting of the Fab and virus structures into the cryoEM densities identified the footprints of each antibody on the viral surface. As anticipated from earlier analyses, the Fab binding sites are directed to two epitopes, A and B. The A site is on an exposed part of the surface near an icosahedral threefold axis, whereas the B site is about equidistant from the surrounding five-, three-, and twofold axes. One antibody directed to the A site binds CPV but not FPV. Two of the antibodies directed to the B site neutralize the virus as Fab fragments. The differences in antibody properties have been linked to the amino acids within the antibody footprints, the position of the binding site relative to the icosahedral symmetry elements, and the orientation of the Fab structure relative to the surface of the virus. Most of the exposed surface area was antigenic, although each of the antibodies had a common area of overlap that coincided with the positions of the previously mapped escape mutations.

Articles - 3iy1 mentioned but not cited (1)

  1. Structural comparison of different antibodies interacting with parvovirus capsids. Hafenstein S, Bowman VD, Sun T, Nelson CD, Palermo LM, Chipman PR, Battisti AJ, Parrish CR, Rossmann MG. J. Virol. 83 5556-5566 (2009)


Reviews citing this publication (8)

  1. Mapping the AAV Capsid Host Antibody Response toward the Development of Second Generation Gene Delivery Vectors. Tseng YS, Agbandje-McKenna M. Front Immunol 5 9 (2014)
  2. Structure of viruses: a short history. Rossmann MG. Q. Rev. Biophys. 46 133-180 (2013)
  3. Requirements for empirical immunogenicity trials, rather than structure-based design, for developing an effective HIV vaccine. Van Regenmortel MH. Arch. Virol. 157 1-20 (2012)
  4. Feline panleukopenia virus: its interesting evolution and current problems in immunoprophylaxis against a serious pathogen. Truyen U, Parrish CR. Vet. Microbiol. 165 29-32 (2013)
  5. Parvovirus Capsid-Antibody Complex Structures Reveal Conservation of Antigenic Epitopes Across the Family. Emmanuel SN, Mietzsch M, Tseng YS, Smith JK, Agbandje-McKenna M. Viral Immunol 34 3-17 (2021)
  6. Twenty-Five Years of Structural Parvovirology. Mietzsch M, Pénzes JJ, Agbandje-McKenna M. Viruses 11 (2019)
  7. Small but mighty: old and new parvoviruses of veterinary significance. Jager MC, Tomlinson JE, Lopez-Astacio RA, Parrish CR, Van de Walle GR. Virol J 18 210 (2021)
  8. The Structures and Functions of Parvovirus Capsids and Missing Pieces: the Viral DNA and Its Packaging, Asymmetrical Features, Nonprotein Components, and Receptor or Antibody Binding and Interactions. López-Astacio RA, Adu OF, Lee H, Hafenstein SL, Parrish CR. J Virol 97 e0016123 (2023)

Articles citing this publication (47)

  1. The emergence of parvoviruses of carnivores. Hoelzer K, Parrish CR. Vet. Res. 41 39 (2010)
  2. Antigen-antibody interface properties: composition, residue interactions, and features of 53 non-redundant structures. Ramaraj T, Angel T, Dratz EA, Jesaitis AJ, Mumey B. Biochim. Biophys. Acta 1824 520-532 (2012)
  3. Capsid antibodies to different adeno-associated virus serotypes bind common regions. Gurda BL, DiMattia MA, Miller EB, Bennett A, McKenna R, Weichert WS, Nelson CD, Chen WJ, Muzyczka N, Olson NH, Sinkovits RS, Chiorini JA, Zolotutkhin S, Kozyreva OG, Samulski RJ, Baker TS, Parrish CR, Agbandje-McKenna M. J. Virol. 87 9111-9124 (2013)
  4. Structure of adeno-associated virus-2 in complex with neutralizing monoclonal antibody A20. McCraw DM, O'Donnell JK, Taylor KA, Stagg SM, Chapman MS. Virology 431 40-49 (2012)
  5. Role of multiple hosts in the cross-species transmission and emergence of a pandemic parvovirus. Allison AB, Harbison CE, Pagan I, Stucker KM, Kaelber JT, Brown JD, Ruder MG, Keel MK, Dubovi EJ, Holmes EC, Parrish CR. J. Virol. 86 865-872 (2012)
  6. A strain-specific epitope of enterovirus 71 identified by cryo-electron microscopy of the complex with fab from neutralizing antibody. Lee H, Cifuente JO, Ashley RE, Conway JF, Makhov AM, Tano Y, Shimizu H, Nishimura Y, Hafenstein S. J. Virol. 87 11363-11370 (2013)
  7. A cryo-electron microscopy study identifies the complete H16.V5 epitope and reveals global conformational changes initiated by binding of the neutralizing antibody fragment. Lee H, Brendle SA, Bywaters SM, Guan J, Ashley RE, Yoder JD, Makhov AM, Conway JF, Christensen ND, Hafenstein S. J. Virol. 89 1428-1438 (2015)
  8. Examining the cross-reactivity and neutralization mechanisms of a panel of mAbs against adeno-associated virus serotypes 1 and 5. Harbison CE, Weichert WS, Gurda BL, Chiorini JA, Agbandje-McKenna M, Parrish CR. J. Gen. Virol. 93 347-355 (2012)
  9. Structural comparison of four different antibodies interacting with human papillomavirus 16 and mechanisms of neutralization. Guan J, Bywaters SM, Brendle SA, Lee H, Ashley RE, Makhov AM, Conway JF, Christensen ND, Hafenstein S. Virology 483 253-263 (2015)
  10. The role of evolutionary intermediates in the host adaptation of canine parvovirus. Stucker KM, Pagan I, Cifuente JO, Kaelber JT, Lillie TD, Hafenstein S, Holmes EC, Parrish CR. J. Virol. 86 1514-1521 (2012)
  11. Adeno-associated virus serotype 1 (AAV1)- and AAV5-antibody complex structures reveal evolutionary commonalities in parvovirus antigenic reactivity. Tseng YS, Gurda BL, Chipman P, McKenna R, Afione S, Chiorini JA, Muzyczka N, Olson NH, Baker TS, Kleinschmidt J, Agbandje-McKenna M. J. Virol. 89 1794-1808 (2015)
  12. Structure-guided evolution of antigenically distinct adeno-associated virus variants for immune evasion. Tse LV, Klinc KA, Madigan VJ, Castellanos Rivera RM, Wells LF, Havlik LP, Smith JK, Agbandje-McKenna M, Asokan A. Proc. Natl. Acad. Sci. U.S.A. 114 E4812-E4821 (2017)
  13. Structural Basis for Recognition of Human Enterovirus 71 by a Bivalent Broadly Neutralizing Monoclonal Antibody. Ye X, Fan C, Ku Z, Zuo T, Kong L, Zhang C, Shi J, Liu Q, Chen T, Zhang Y, Jiang W, Zhang L, Huang Z, Cong Y. PLoS Pathog. 12 e1005454 (2016)
  14. Global displacement of canine parvovirus by a host-adapted variant: structural comparison between pandemic viruses with distinct host ranges. Organtini LJ, Allison AB, Lukk T, Parrish CR, Hafenstein S. J. Virol. 89 1909-1912 (2015)
  15. Structural Basis of Human Parechovirus Neutralization by Human Monoclonal Antibodies. Shakeel S, Westerhuis BM, Ora A, Koen G, Bakker AQ, Claassen Y, Wagner K, Beaumont T, Wolthers KC, Butcher SJ. J. Virol. 89 9571-9580 (2015)
  16. Structural characterization of H-1 parvovirus: comparison of infectious virions to empty capsids. Halder S, Nam HJ, Govindasamy L, Vogel M, Dinsart C, Salomé N, McKenna R, Agbandje-McKenna M. J. Virol. 87 5128-5140 (2013)
  17. Self-assembly of virus-like particles of canine parvovirus capsid protein expressed from Escherichia coli and application as virus-like particle vaccine. Xu J, Guo HC, Wei YQ, Dong H, Han SC, Ao D, Sun DH, Wang HM, Cao SZ, Sun SQ. Appl. Microbiol. Biotechnol. 98 3529-3538 (2014)
  18. Mapping Antigenic Epitopes on the Human Bocavirus Capsid. Kailasan S, Garrison J, Ilyas M, Chipman P, McKenna R, Kantola K, Söderlund-Venermo M, Kučinskaitė-Kodzė I, Žvirblienė A, Agbandje-McKenna M. J. Virol. 90 4670-4680 (2016)
  19. The U4 Antibody Epitope on Human Papillomavirus 16 Identified by Cryo-electron Microscopy. Guan J, Bywaters SM, Brendle SA, Lee H, Ashley RE, Christensen ND, Hafenstein S. J. Virol. 89 12108-12117 (2015)
  20. The enterovirus 71 procapsid binds neutralizing antibodies and rescues virus infection in vitro. Shingler KL, Cifuente JO, Ashley RE, Makhov AM, Conway JF, Hafenstein S. J. Virol. 89 1900-1908 (2015)
  21. Single Mutations in the VP2 300 Loop Region of the Three-Fold Spike of the Carnivore Parvovirus Capsid Can Determine Host Range. Allison AB, Organtini LJ, Zhang S, Hafenstein SL, Holmes EC, Parrish CR. J. Virol. 90 753-767 (2016)
  22. Analysis of the full-length VP2 protein of canine parvoviruses circulating in Hungary. Cságola A, Varga S, Lőrincz M, Tuboly T. Arch. Virol. 159 2441-2444 (2014)
  23. Near-Atomic Resolution Structure of a Highly Neutralizing Fab Bound to Canine Parvovirus. Organtini LJ, Lee H, Iketani S, Huang K, Ashley RE, Makhov AM, Conway JF, Parrish CR, Hafenstein S. J. Virol. 90 9733-9742 (2016)
  24. Atomic Resolution Structure of the Oncolytic Parvovirus LuIII by Electron Microscopy and 3D Image Reconstruction. Pittman N, Misseldine A, Geilen L, Halder S, Smith JK, Kurian J, Chipman P, Janssen M, Mckenna R, Baker TS, D'Abramo A, Cotmore S, Tattersall P, Agbandje-McKenna M. Viruses 9 (2017)
  25. Limited Intrahost Diversity and Background Evolution Accompany 40 Years of Canine Parvovirus Host Adaptation and Spread. Voorhees IEH, Lee H, Allison AB, Lopez-Astacio R, Goodman LB, Oyesola OO, Omobowale O, Fagbohun O, Dubovi EJ, Hafenstein SL, Holmes EC, Parrish CR. J Virol 94 (2019)
  26. Parvovirus Capsid Structures Required for Infection: Mutations Controlling Receptor Recognition and Protease Cleavages. Callaway HM, Feng KH, Lee DW, Allison AB, Pinard M, McKenna R, Agbandje-McKenna M, Hafenstein S, Parrish CR. J. Virol. 91 (2017)
  27. Creating an arsenal of Adeno-associated virus (AAV) gene delivery stealth vehicles. Smith JK, Agbandje-McKenna M. PLoS Pathog. 14 e1006929 (2018)
  28. High-resolution asymmetric structure of a Fab-virus complex reveals overlap with the receptor binding site. Goetschius DJ, Hartmann SR, Organtini LJ, Callaway H, Huang K, Bator CM, Ashley RE, Makhov AM, Conway JF, Parrish CR, Hafenstein SL. Proc Natl Acad Sci U S A 118 e2025452118 (2021)
  29. Molecular characterization of canine parvovirus in Vientiane, Laos. Vannamahaxay S, Vongkhamchanh S, Intanon M, Tangtrongsup S, Tiwananthagorn S, Pringproa K, Chuammitri P. Arch. Virol. 162 1355-1361 (2017)
  30. The dimerization of glucagon-like peptide-2 MIMETIBODY™ is linked to leucine-17 in the glucagon-like peptide-2 region. Baker AE, Sague S, Grygiel TL, Schmidt A, Rogers A, Jiang H, Kruszynski M, Nesspor T. J. Mol. Recognit. 25 155-164 (2012)
  31. Antibody escape by polyomavirus capsid mutation facilitates neurovirulence. Lauver MD, Goetschius DJ, Netherby-Winslow CS, Ayers KN, Jin G, Haas DG, Frost EL, Cho SH, Bator CM, Bywaters SM, Christensen ND, Hafenstein SL, Lukacher AE. Elife 9 (2020)
  32. Modulation of Sialic Acid Dependence Influences the Central Nervous System Transduction Profile of Adeno-associated Viruses. Albright BH, Simon KE, Pillai M, Devlin GW, Asokan A. J. Virol. 93 (2019)
  33. Structural basis for the shared neutralization mechanism of three classes of human papillomavirus type 58 antibodies with disparate modes of binding. He M, Chi X, Zha Z, Li Y, Chen J, Huang Y, Huang S, Yu M, Wang Z, Song S, Liu X, Wei S, Li Z, Li T, Wang Y, Yu H, Zhao Q, Zhang J, Zheng Q, Gu Y, Li S, Xia N. J Virol JVI.01587-20 (2021)
  34. Antiangiogenic Vascular Endothelial Growth Factor-Blocking Peptides Displayed on the Capsid of an Infectious Oncolytic Parvovirus: Assembly and Immune Interactions. Grueso E, Sánchez-Martínez C, Calvo-López T, de Miguel FJ, Blanco-Menéndez N, Fernandez-Estevez M, Elizalde M, Sanchez J, Kourani O, Martin D, Tato A, Guerra M, Andrés G, Almendral JM. J Virol 93 (2019)
  35. Complex and Dynamic Interactions between Parvovirus Capsids, Transferrin Receptors, and Antibodies Control Cell Infection and Host Range. Callaway HM, Welsch K, Weichert W, Allison AB, Hafenstein SL, Huang K, Iketani S, Parrish CR. J. Virol. 92 (2018)
  36. Cryo EM structures map a post vaccination polyclonal antibody response to canine parvovirus. Hartmann SR, Charnesky AJ, Früh SP, López-Astacio RA, Weichert WS, DiNunno N, Cho SH, Bator CM, Parrish CR, Hafenstein SL. Commun Biol 6 955 (2023)
  37. Epidemiology and diagnosis of feline panleukopenia virus in Egypt: Clinical and molecular diagnosis in cats. Awad RA, Khalil WKB, Attallah AG. Vet World 11 578-584 (2018)
  38. Evidence of CPV2c introgression into Croatia and novel insights into phylogeny and cell tropism. Novosel D, Tuboly T, Balka G, Szeredi L, Lojkic I, Jungic A, Acinger-Rogic Z, Ait-Ali T, Csagola A. Sci Rep 9 16909 (2019)
  39. Feline Panleukopenia Virus With G299E Substitution in the VP2 Protein First Identified From a Captive Giant Panda in China. Yi S, Liu S, Meng X, Huang P, Cao Z, Jin H, Wang J, Hu G, Lan J, Zhang D, Gao Y, Wang H, Li N, Feng N, Hou R, Yang S, Xia X. Front Cell Infect Microbiol 11 820144 (2021)
  40. Feline panleukopenia viral infection in cats: Application of some molecular methods used for its diagnosis. Awad RA, Khalil WKB, Attallah AG. J Genet Eng Biotechnol 16 491-497 (2018)
  41. High-Resolution Structure Analysis of Antibody V5 and U4 Conformational Epitopes on Human Papillomavirus 16. Guan J, Bywaters SM, Brendle SA, Ashley RE, Makhov AM, Conway JF, Christensen ND, Hafenstein S. Viruses 9 (2017)
  42. Isolation, cloning and analysis of parvovirus-specific canine antibodies from peripheral blood B cells. Früh SP, Adu OF, López-Astacio RA, Weichert WS, Wasik BR, Parrish CR. Dev Comp Immunol 147 104894 (2023)
  43. Molecular characterization of canine parvovirus from domestic dogs in Nigeria: Introduction and spread of a CPV-2c mutant and replacement of older CPV-2a by the "new CPV-2a" strain. Ndiana LA, Odaibo GN, Olaleye DO. Virusdisease 32 361-368 (2021)
  44. Molecular epidemiology of canine parvovirus type 2 in Italy from 1994 to 2017: recurrence of the CPV-2b variant. Battilani M, Modugno F, Mira F, Purpari G, Di Bella S, Guercio A, Balboni A. BMC Vet. Res. 15 393 (2019)
  45. Structural Characterization of Cuta- and Tusavirus: Insight into Protoparvoviruses Capsid Morphology. Mietzsch M, McKenna R, Väisänen E, Yu JC, Ilyas M, Hull JA, Kurian J, Smith JK, Chipman P, Lasanajak Y, Smith D, Söderlund-Venermo M, Agbandje-McKenna M. Viruses 12 (2020)
  46. Transferrin receptor binds virus capsid with dynamic motion. Lee H, Callaway HM, Cifuente JO, Bator CM, Parrish CR, Hafenstein SL. Proc. Natl. Acad. Sci. U.S.A. 116 20462-20471 (2019)
  47. Viral Capsid, Antibody, and Receptor Interactions: Experimental Analysis of the Antibody Escape Evolution of Canine Parvovirus. López-Astacio RA, Adu OF, Goetschius DJ, Lee H, Weichert WS, Wasik BR, Frueh SP, Alford BK, Voorhees IEH, Flint JF, Saddoris S, Goodman LB, Holmes EC, Hafenstein SL, Parrish CR. J Virol 97 e0009023 (2023)


Quick links